Henry Schein Inc (HSIC)

Industry Medical Distribution


This stock can be held in an Investment ISA and an Investment Account
Sell

$73.46

Buy

$74.31

arrow-down$-0.66 (-0.88%)

Prices updated at 01 May 2026, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Henry Schein Inc is a provider of healthcare products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics.
Sector
Healthcare
Industry
Medical Distribution
Chairman
Mr. Stanley M. Bergman
CEO
Mr. R. Steven Boggan
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
25,000
Head office
135 Duryea Road
Melville
United States
11747
mobile
+1 631 843-5500
letter
carolynne.borders@henryschein.com

Key personnel

Salary
Mr. Stanley M. Bergman
Chairman of the Board
1.71m
Mr. Frederick M. Lowery
Director and Chief Executive Officer
-
Dr. Bradley T. Sheares, PhD
Independent Director
0.17m
Ms. Deborah M. Derby
Independent Director
0.17m
Mr. Joseph L. Herring
Independent Director
0.15m
Mr. Kurt P. Kuehn
Independent Director
0.15m
Mr. Mark E. Mlotek
Executive Vice President and Chief Strategic Officer
0.75m
Mr. Philip A. Laskawy
Lead Independent Director
0.19m
Mr. William K. Daniel
Independent Director
0.08m
Mr. Robert J. Hombach
Independent Director
0.10m
Dr. Reed V. Tuckson, M.D.
Independent Director
0.11m
Mr. Michael S. Ettinger
Executive Vice President and Chief Operating Officer
0.75m
Mr. Mohamad Ali
Independent Director
0.13m
Mr. Max C. Lin
Independent Director
0.10m
Ms. Anne H. Margulies
Independent Director
0.12m
Mr. Christopher Pendergast
Senior Vice President and Chief Technology Officer
-
Mr. James Mullins
Senior Vice President, Global Supply Chain
-
Mr. Scott P. Serota
Independent Director
0.13m
Ms. Carole T. Faig
Independent Director
0.12m
Mr. Ronald N. South
Senior Vice President, Principal Accounting Officer and Chief Financial Officer
0.64m
Mr. Andrea Albertini
Chief Executive Officer, Global Distribution and Technology
0.71m
Ms. Kelly Murphy
Senior Vice President and General Counsel
-
Mr. Tom Popeck
Chief Executive Officer, Henry Schein Products Group
-
Mr. R. Steven Boggan
Chief Executive Officer, Global Oral Reconstruction Group, Americas
-
Ms. Christine Sheehy
Senior Vice President and Chief Human Resources Officer
-
Mr. David Kochman
Senior Vice President and Chief Corporate Affairs Officer
-

Top 5 shareholders

No. of shares
Kohlberg Kravis Roberts & Co LP15,652,032
Vanguard Group Inc11,588,199
BlackRock Inc6,959,174
Artisan Partners Limited Partnership6,647,378
JPMorgan Chase & Co5,101,448

Director dealings

Action
10 Dec 2025-
25 Nov 2025-
24 Nov 2025-
19 Nov 2025-
13 Nov 2025-
10 Sep 2025-
13 Aug 2025-
07 Aug 2025-
13 Jun 2025-
13 Jun 2025-
11 Jun 2025-
09 Jun 2025-
30 May 2025-
21 May 2025-
16 May 2025-
09 May 2025-
19 Mar 2025-
19 Mar 2025-
18 Mar 2025-
19 Mar 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.